Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
59.31 M EUR
6.59 B EUR
291.12 M
About GRIFOLS S.A.
Sector
CEO
Nacho Abia
Headquarters
Barcelona
Website
Founded
1940
ISIN
ES0171996087
FIGI
BBG000VD6WL6
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
GRFS5271380
Grifols Escrow Issuer SA 4.75% 15-OCT-2028Yield to maturity
6.55%
Maturity date
Oct 15, 2028
Explore more bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange GRIFOLS SA stocks are traded under the ticker GRFE.
We've gathered analysts' opinions on GRIFOLS SA future price: according to them, GRFE price has a max estimate of 27.00 EUR and a min estimate of 9.00 EUR. Watch GRFE chart and read a more detailed GRIFOLS SA stock forecast: see what analysts think of GRIFOLS SA and suggest that you do with its stocks.
GRFE reached its all-time high on Feb 20, 2020 with the price of 34.305 EUR, and its all-time low was 6.020 EUR and was reached on Dec 15, 2011. View more price dynamics on GRFE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track GRIFOLS SA financials in yearly and quarterly reports right on TradingView.
GRIFOLS SA is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
GRFE earnings for the last quarter are 0.23 EUR per share, whereas the estimation was 0.20 EUR resulting in a 14.90% surprise. The estimated earnings for the next quarter are 0.19 EUR per share. See more details about GRIFOLS SA earnings.
GRIFOLS SA revenue for the last quarter amounts to 1.79 B EUR, despite the estimated figure of 1.76 B EUR. In the next quarter, revenue is expected to reach 1.87 B EUR.
GRFE net income for the last quarter is 51.69 M EUR, while the quarter before that showed 14.84 M EUR of net income which accounts for 248.30% change. Track more GRIFOLS SA financial stats to get the full picture.
GRIFOLS SA dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has 23.74 K employees. See our rating of the largest employees — is GRIFOLS SA on this list?
Like other stocks, GRFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRIFOLS SA stock right from TradingView charts — choose your broker and connect to your account.